Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Ease - MMP sale, & Bibeau buys.. Opty... imho, no, you're wrong. eom
5
Apr 17, 2009 02:51PM

<The outcome sought by PTSC backers was not to receive a final office action from the USPTO re: the 336.>

IMHO the outcome shareholders want is recertification of enough of the MMP as to make the portfolio licenseable. I still think that outcome is quite possible.

But to answer your specific questions.

No, I have no authority to overrule the USPTO and never claimed I did.

As far as whether the USPTO's rejections are on solid ground - Why would you think that some authority is needed to have any opinion about that? Every shareholder who has any significant amt of $ invested in PTSC should have read the '336 rejection at least twice, listened to what others say, and formed some opinion on it. I see nothing wrong with voicing one's opinion on such an important issue. Have you formed an opinion about the '336 final office action?

Opty

Share
New Message
Please login to post a reply